A signal finding study of SAR 252067 in severe pediartic onset Inflammatory Bowel Disease (IBD)

Trial Profile

A signal finding study of SAR 252067 in severe pediartic onset Inflammatory Bowel Disease (IBD)

Planning
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs AEVI 002 (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Therapeutic Use
  • Sponsors Aevi Genomic Medicine
  • Most Recent Events

    • 13 Jun 2016 New trial record
    • 06 Jun 2016 According to a Medgenics Inc media release, data from this trial is expected in the first half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top